Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Body Composition | 29 | 2024 | 521 | 2.650 |
Why?
|
Absorptiometry, Photon | 24 | 2022 | 177 | 1.760 |
Why?
|
Adipose Tissue | 14 | 2020 | 460 | 1.330 |
Why?
|
Whole-Body Counting | 4 | 2017 | 6 | 1.140 |
Why?
|
Bone Density | 22 | 2022 | 318 | 1.130 |
Why?
|
Phantoms, Imaging | 6 | 2013 | 131 | 1.120 |
Why?
|
Bone and Bones | 10 | 2022 | 265 | 0.690 |
Why?
|
Radiation Monitoring | 1 | 2017 | 13 | 0.560 |
Why?
|
Thallium | 1 | 2017 | 9 | 0.560 |
Why?
|
Iodides | 1 | 2017 | 15 | 0.560 |
Why?
|
Sodium | 4 | 2017 | 295 | 0.540 |
Why?
|
Monte Carlo Method | 2 | 2017 | 95 | 0.490 |
Why?
|
Renal Dialysis | 2 | 2018 | 846 | 0.460 |
Why?
|
Whole Body Imaging | 1 | 2013 | 29 | 0.430 |
Why?
|
Models, Anatomic | 1 | 2013 | 99 | 0.400 |
Why?
|
Energy Metabolism | 4 | 2024 | 774 | 0.380 |
Why?
|
Pediatric Obesity | 4 | 2022 | 382 | 0.380 |
Why?
|
Body Mass Index | 7 | 2024 | 1555 | 0.370 |
Why?
|
Body Weight | 11 | 2017 | 996 | 0.350 |
Why?
|
Calibration | 4 | 2022 | 89 | 0.320 |
Why?
|
Child | 30 | 2024 | 24361 | 0.310 |
Why?
|
Models, Biological | 6 | 2024 | 1453 | 0.310 |
Why?
|
Basal Metabolism | 3 | 2024 | 95 | 0.300 |
Why?
|
Weight Gain | 4 | 2019 | 404 | 0.280 |
Why?
|
Pregnancy, Twin | 2 | 2018 | 179 | 0.280 |
Why?
|
beta-Glucans | 3 | 2013 | 19 | 0.280 |
Why?
|
Obesity | 8 | 2019 | 2257 | 0.280 |
Why?
|
Breast Feeding | 2 | 2020 | 218 | 0.280 |
Why?
|
Insulin Resistance | 3 | 2022 | 637 | 0.270 |
Why?
|
Isoflavones | 3 | 2013 | 45 | 0.270 |
Why?
|
Adolescent | 23 | 2024 | 19247 | 0.260 |
Why?
|
Infant, Premature | 5 | 2020 | 813 | 0.260 |
Why?
|
Milk, Human | 2 | 2020 | 299 | 0.250 |
Why?
|
Fetal Development | 2 | 2018 | 132 | 0.250 |
Why?
|
Child, Preschool | 18 | 2024 | 14004 | 0.240 |
Why?
|
Anthropometry | 5 | 2018 | 197 | 0.240 |
Why?
|
Calorimetry | 1 | 2024 | 61 | 0.240 |
Why?
|
Software | 3 | 2008 | 677 | 0.230 |
Why?
|
Humans | 54 | 2024 | 124122 | 0.230 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2005 | 218 | 0.210 |
Why?
|
Adiposity | 3 | 2022 | 190 | 0.200 |
Why?
|
Cardiorespiratory Fitness | 1 | 2022 | 10 | 0.200 |
Why?
|
Potassium | 7 | 2015 | 280 | 0.200 |
Why?
|
Female | 37 | 2024 | 66250 | 0.200 |
Why?
|
Osteoporosis | 2 | 2019 | 116 | 0.190 |
Why?
|
Pregnancy Trimesters | 2 | 2018 | 34 | 0.190 |
Why?
|
Male | 32 | 2024 | 60978 | 0.190 |
Why?
|
Body Height | 4 | 2018 | 215 | 0.180 |
Why?
|
Dietary Supplements | 4 | 2018 | 476 | 0.180 |
Why?
|
Osteosclerosis | 1 | 2020 | 12 | 0.180 |
Why?
|
Exercise | 3 | 2021 | 787 | 0.170 |
Why?
|
Reproducibility of Results | 9 | 2008 | 2862 | 0.170 |
Why?
|
Reference Values | 7 | 2018 | 711 | 0.170 |
Why?
|
Osteogenesis Imperfecta | 1 | 2022 | 148 | 0.170 |
Why?
|
Birth Weight | 2 | 2018 | 346 | 0.170 |
Why?
|
Limb Deformities, Congenital | 1 | 2020 | 106 | 0.160 |
Why?
|
Dwarfism | 1 | 2020 | 100 | 0.160 |
Why?
|
Postmenopause | 2 | 2010 | 126 | 0.160 |
Why?
|
Calcium | 7 | 2009 | 1099 | 0.160 |
Why?
|
Infant | 11 | 2020 | 12457 | 0.160 |
Why?
|
Young Adult | 5 | 2024 | 8983 | 0.150 |
Why?
|
Twins, Dizygotic | 1 | 2018 | 42 | 0.150 |
Why?
|
Age Factors | 7 | 2011 | 2806 | 0.150 |
Why?
|
Docosahexaenoic Acids | 1 | 2019 | 66 | 0.150 |
Why?
|
Craniofacial Abnormalities | 1 | 2020 | 242 | 0.150 |
Why?
|
Spectrum Analysis | 1 | 2018 | 62 | 0.150 |
Why?
|
Minerals | 1 | 1998 | 57 | 0.150 |
Why?
|
Skeleton | 1 | 1998 | 5 | 0.150 |
Why?
|
Urogenital Abnormalities | 1 | 2020 | 154 | 0.150 |
Why?
|
Body Water | 5 | 2018 | 89 | 0.150 |
Why?
|
Overweight | 2 | 2024 | 362 | 0.140 |
Why?
|
Child Development | 1 | 2020 | 266 | 0.140 |
Why?
|
Scintillation Counting | 1 | 2017 | 6 | 0.140 |
Why?
|
Infant Nutritional Physiological Phenomena | 2 | 2017 | 193 | 0.140 |
Why?
|
Cross-Sectional Studies | 6 | 2024 | 3414 | 0.140 |
Why?
|
Adult | 19 | 2022 | 29322 | 0.140 |
Why?
|
Rothmund-Thomson Syndrome | 1 | 2017 | 47 | 0.140 |
Why?
|
Equipment Failure Analysis | 1 | 2017 | 83 | 0.140 |
Why?
|
Genetic Association Studies | 1 | 2020 | 782 | 0.130 |
Why?
|
Infant, Newborn | 10 | 2020 | 8180 | 0.130 |
Why?
|
Infant Formula | 1 | 2017 | 97 | 0.130 |
Why?
|
Nutritional Status | 1 | 2018 | 313 | 0.130 |
Why?
|
Proteins | 2 | 2018 | 1035 | 0.130 |
Why?
|
Energy Intake | 1 | 2018 | 493 | 0.130 |
Why?
|
Fractures, Bone | 1 | 2017 | 186 | 0.120 |
Why?
|
Diet | 3 | 2020 | 1133 | 0.120 |
Why?
|
Equipment Design | 1 | 2017 | 586 | 0.120 |
Why?
|
Regression Analysis | 4 | 2008 | 777 | 0.120 |
Why?
|
Swine | 6 | 2019 | 1177 | 0.120 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2015 | 48 | 0.120 |
Why?
|
Computer Simulation | 1 | 2017 | 646 | 0.110 |
Why?
|
Hypertension | 1 | 2022 | 1316 | 0.110 |
Why?
|
Polyvinyl Chloride | 1 | 2013 | 1 | 0.110 |
Why?
|
Polyethylene | 1 | 2013 | 16 | 0.110 |
Why?
|
Nylons | 1 | 2013 | 12 | 0.110 |
Why?
|
Kidney Transplantation | 1 | 2019 | 638 | 0.110 |
Why?
|
Quality of Life | 2 | 2013 | 1899 | 0.110 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 271 | 0.110 |
Why?
|
Longitudinal Studies | 1 | 2017 | 1317 | 0.100 |
Why?
|
Bariatric Surgery | 1 | 2015 | 116 | 0.100 |
Why?
|
Camping | 1 | 2013 | 13 | 0.100 |
Why?
|
Menopause | 1 | 2013 | 75 | 0.100 |
Why?
|
Weight Loss | 2 | 2015 | 480 | 0.100 |
Why?
|
Obesity, Morbid | 1 | 2015 | 181 | 0.100 |
Why?
|
Weight Reduction Programs | 1 | 2013 | 55 | 0.100 |
Why?
|
Self Concept | 1 | 2013 | 154 | 0.090 |
Why?
|
Metabolic Syndrome | 1 | 2015 | 338 | 0.090 |
Why?
|
Growth and Development | 1 | 2011 | 22 | 0.090 |
Why?
|
Phytoestrogens | 1 | 2010 | 16 | 0.090 |
Why?
|
Blood Urea Nitrogen | 1 | 2010 | 73 | 0.090 |
Why?
|
Neutron Activation Analysis | 4 | 1999 | 7 | 0.090 |
Why?
|
Cohort Studies | 5 | 2024 | 4778 | 0.090 |
Why?
|
Marfan Syndrome | 1 | 2012 | 140 | 0.090 |
Why?
|
Growth Hormone-Releasing Hormone | 1 | 2009 | 11 | 0.080 |
Why?
|
Plant Extracts | 1 | 2010 | 118 | 0.080 |
Why?
|
Injections, Intramuscular | 1 | 2009 | 195 | 0.080 |
Why?
|
Growth Hormone | 1 | 2009 | 150 | 0.080 |
Why?
|
Plasmids | 1 | 2009 | 510 | 0.080 |
Why?
|
Body Fluid Compartments | 2 | 2018 | 19 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2008 | 2037 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 875 | 0.070 |
Why?
|
Risk Factors | 4 | 2022 | 10241 | 0.070 |
Why?
|
Plethysmography | 1 | 2007 | 35 | 0.070 |
Why?
|
Placebos | 4 | 2013 | 240 | 0.070 |
Why?
|
Potassium Radioisotopes | 3 | 2015 | 6 | 0.070 |
Why?
|
Sex Factors | 2 | 2008 | 1276 | 0.060 |
Why?
|
Vitamin D | 3 | 2018 | 160 | 0.060 |
Why?
|
Body Constitution | 2 | 1998 | 36 | 0.060 |
Why?
|
Gestational Age | 3 | 2018 | 1160 | 0.060 |
Why?
|
Pregnancy | 4 | 2019 | 7164 | 0.060 |
Why?
|
Software Validation | 1 | 2004 | 11 | 0.060 |
Why?
|
Lumbar Vertebrae | 2 | 2022 | 113 | 0.060 |
Why?
|
Prospective Studies | 4 | 2019 | 6117 | 0.060 |
Why?
|
Middle Aged | 8 | 2020 | 26583 | 0.060 |
Why?
|
Receptors, Calcitriol | 1 | 2005 | 70 | 0.060 |
Why?
|
Femur | 2 | 2020 | 67 | 0.060 |
Why?
|
Indicator Dilution Techniques | 1 | 2022 | 24 | 0.050 |
Why?
|
Evaluation Studies as Topic | 2 | 1993 | 256 | 0.050 |
Why?
|
Deuterium | 1 | 2022 | 109 | 0.050 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 1941 | 0.050 |
Why?
|
Blood Pressure Determination | 1 | 2022 | 106 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 810 | 0.050 |
Why?
|
Wnt-5a Protein | 1 | 2020 | 21 | 0.040 |
Why?
|
Soybean Proteins | 1 | 2000 | 17 | 0.040 |
Why?
|
Dishevelled Proteins | 1 | 2020 | 43 | 0.040 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2020 | 34 | 0.040 |
Why?
|
Glypicans | 1 | 2020 | 39 | 0.040 |
Why?
|
Arthritis, Juvenile | 1 | 2000 | 43 | 0.040 |
Why?
|
Linear Models | 1 | 2001 | 668 | 0.040 |
Why?
|
Olive Oil | 1 | 2019 | 22 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 456 | 0.040 |
Why?
|
Emulsions | 1 | 2019 | 69 | 0.040 |
Why?
|
Soybean Oil | 1 | 2019 | 70 | 0.040 |
Why?
|
Population Surveillance | 1 | 2001 | 388 | 0.040 |
Why?
|
Aftercare | 1 | 2020 | 148 | 0.040 |
Why?
|
Fish Oils | 1 | 2019 | 83 | 0.040 |
Why?
|
Dietary Proteins | 1 | 2000 | 250 | 0.040 |
Why?
|
Living Donors | 1 | 2019 | 109 | 0.040 |
Why?
|
Animals | 8 | 2019 | 34002 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2013 | 1629 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2000 | 317 | 0.040 |
Why?
|
Thinness | 1 | 1998 | 70 | 0.040 |
Why?
|
Nutritional Requirements | 1 | 2018 | 181 | 0.040 |
Why?
|
Medroxyprogesterone | 1 | 1997 | 8 | 0.040 |
Why?
|
Amenorrhea | 1 | 1997 | 20 | 0.040 |
Why?
|
Contraceptives, Oral | 1 | 1997 | 37 | 0.030 |
Why?
|
Bone Remodeling | 1 | 2017 | 55 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2020 | 314 | 0.030 |
Why?
|
RecQ Helicases | 1 | 2017 | 62 | 0.030 |
Why?
|
Blood Pressure | 1 | 2022 | 1350 | 0.030 |
Why?
|
Postpartum Period | 1 | 2018 | 215 | 0.030 |
Why?
|
Models, Structural | 2 | 1994 | 50 | 0.030 |
Why?
|
Texas | 4 | 2015 | 3580 | 0.030 |
Why?
|
Hypothalamic Diseases | 1 | 1997 | 37 | 0.030 |
Why?
|
Lactation | 1 | 2018 | 193 | 0.030 |
Why?
|
Triglycerides | 1 | 2019 | 573 | 0.030 |
Why?
|
Osteogenesis | 1 | 2017 | 154 | 0.030 |
Why?
|
Patient Discharge | 1 | 2020 | 487 | 0.030 |
Why?
|
Prevalence | 1 | 2022 | 2444 | 0.030 |
Why?
|
Pilot Projects | 1 | 2020 | 1369 | 0.030 |
Why?
|
Wasting Syndrome | 1 | 2015 | 25 | 0.030 |
Why?
|
Mothers | 1 | 2018 | 352 | 0.030 |
Why?
|
Pregnancy Outcome | 1 | 2018 | 588 | 0.030 |
Why?
|
Peptide YY | 1 | 2015 | 19 | 0.030 |
Why?
|
Analysis of Variance | 3 | 2005 | 1008 | 0.030 |
Why?
|
Pennsylvania | 1 | 2015 | 53 | 0.030 |
Why?
|
Gastrointestinal Hormones | 1 | 2015 | 23 | 0.030 |
Why?
|
Adipokines | 1 | 2015 | 58 | 0.030 |
Why?
|
Neurodevelopmental Disorders | 1 | 2020 | 505 | 0.030 |
Why?
|
Genetic Variation | 1 | 2020 | 1493 | 0.030 |
Why?
|
Leptin | 1 | 2015 | 216 | 0.030 |
Why?
|
Time Factors | 4 | 2009 | 6279 | 0.030 |
Why?
|
Elements | 1 | 1993 | 1 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 1102 | 0.030 |
Why?
|
Gamma Rays | 1 | 1993 | 49 | 0.030 |
Why?
|
Fibrillins | 1 | 2012 | 31 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2019 | 12275 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2004 | 2139 | 0.030 |
Why?
|
Pediatrics | 2 | 2018 | 1157 | 0.030 |
Why?
|
Fibrillin-1 | 1 | 2012 | 58 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 2087 | 0.020 |
Why?
|
Tissue Distribution | 1 | 1993 | 382 | 0.020 |
Why?
|
Infant, Low Birth Weight | 1 | 1993 | 167 | 0.020 |
Why?
|
Seasons | 1 | 2013 | 310 | 0.020 |
Why?
|
Hypocotyl | 1 | 2010 | 6 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2015 | 777 | 0.020 |
Why?
|
Program Evaluation | 1 | 2013 | 442 | 0.020 |
Why?
|
United States | 2 | 2022 | 10856 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2012 | 273 | 0.020 |
Why?
|
Endometrium | 1 | 2013 | 281 | 0.020 |
Why?
|
Insulin | 1 | 2015 | 1200 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 54 | 0.020 |
Why?
|
Europe | 2 | 2000 | 352 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 944 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 1 | 2009 | 186 | 0.020 |
Why?
|
Mexican Americans | 2 | 2000 | 204 | 0.020 |
Why?
|
Ultrasonography | 1 | 2013 | 931 | 0.020 |
Why?
|
Sex Characteristics | 2 | 2000 | 314 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2009 | 340 | 0.020 |
Why?
|
Eating | 1 | 2009 | 374 | 0.020 |
Why?
|
Brain | 1 | 2019 | 2979 | 0.020 |
Why?
|
Biomarkers | 1 | 2015 | 3046 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 1683 | 0.020 |
Why?
|
Inulin | 1 | 2005 | 18 | 0.020 |
Why?
|
Fructans | 1 | 2005 | 10 | 0.020 |
Why?
|
Osteocalcin | 1 | 2005 | 42 | 0.010 |
Why?
|
Immunoassay | 1 | 2005 | 130 | 0.010 |
Why?
|
Femur Neck | 1 | 2004 | 9 | 0.010 |
Why?
|
Chlorine | 2 | 1994 | 14 | 0.010 |
Why?
|
Polysaccharides | 1 | 2005 | 140 | 0.010 |
Why?
|
Hip Joint | 1 | 2004 | 34 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 5827 | 0.010 |
Why?
|
Surveys and Questionnaires | 1 | 2013 | 3682 | 0.010 |
Why?
|
Spine | 1 | 2004 | 143 | 0.010 |
Why?
|
Kinetics | 1 | 2005 | 1321 | 0.010 |
Why?
|
Models, Animal | 1 | 2004 | 459 | 0.010 |
Why?
|
Dermatomyositis | 1 | 2001 | 21 | 0.010 |
Why?
|
Mice | 1 | 2017 | 17582 | 0.010 |
Why?
|
Animal Feed | 1 | 2000 | 79 | 0.010 |
Why?
|
Electric Impedance | 1 | 1999 | 57 | 0.010 |
Why?
|
Electric Conductivity | 1 | 1999 | 87 | 0.010 |
Why?
|
New York | 1 | 1999 | 69 | 0.010 |
Why?
|
Growth | 1 | 1999 | 106 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 2557 | 0.010 |
Why?
|
Cystic Fibrosis | 1 | 2001 | 257 | 0.010 |
Why?
|
Random Allocation | 1 | 1999 | 435 | 0.010 |
Why?
|
Rett Syndrome | 1 | 2001 | 291 | 0.010 |
Why?
|
Algorithms | 1 | 2004 | 1606 | 0.010 |
Why?
|
Liver Diseases | 1 | 2001 | 365 | 0.010 |
Why?
|
Phosphorus | 1 | 1994 | 56 | 0.010 |
Why?
|
Patient Compliance | 1 | 1997 | 469 | 0.010 |
Why?
|
Cadaver | 1 | 1993 | 129 | 0.010 |
Why?
|
HIV Infections | 1 | 2001 | 1890 | 0.010 |
Why?
|